Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting inflammation in diabetic nephropathy: a tale of hope.
Moreno JA, Gomez-Guerrero C, Mas S, Sanz AB, Lorenzo O, Ruiz-Ortega M, Opazo L, Mezzano S, Egido J. Moreno JA, et al. Among authors: mezzano s. Expert Opin Investig Drugs. 2018 Nov;27(11):917-930. doi: 10.1080/13543784.2018.1538352. Epub 2018 Oct 23. Expert Opin Investig Drugs. 2018. PMID: 30334635 Review.
Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
Lavoz C, Rayego-Mateos S, Orejudo M, Opazo-Ríos L, Marchant V, Marquez-Exposito L, Tejera-Muñoz A, Navarro-González JF, Droguett A, Ortiz A, Egido J, Mezzano S, Rodrigues-Diez RR, Ruiz-Ortega M. Lavoz C, et al. Among authors: mezzano s. J Clin Med. 2020 Jan 19;9(1):272. doi: 10.3390/jcm9010272. J Clin Med. 2020. PMID: 31963845 Free PMC article. Review.
Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy.
Opazo-Ríos L, Plaza A, Sánchez Matus Y, Bernal S, Lopez-Sanz L, Jimenez-Castilla L, Carpio D, Droguett A, Mezzano S, Egido J, Gomez-Guerrero C. Opazo-Ríos L, et al. Among authors: mezzano s. Int J Mol Sci. 2020 Jun 13;21(12):4225. doi: 10.3390/ijms21124225. Int J Mol Sci. 2020. PMID: 32545818 Free PMC article.
Interleukin-17A: Possible mediator and therapeutic target in hypertension.
Rodrigues-Diez RR, Tejera-Muñoz A, Orejudo M, Marquez-Exposito L, Santos L, Rayego-Mateos S, Cantero-Navarro E, Tejedor-Santamaria L, Marchant V, Ortiz A, Egido J, Mezzano S, Selgas R, Navarro-González JF, Valdivielso JM, Lavoz C, Ruiz-Ortega M. Rodrigues-Diez RR, et al. Among authors: mezzano s. Nefrologia (Engl Ed). 2021 May-Jun;41(3):244-257. doi: 10.1016/j.nefro.2020.11.009. Epub 2021 Mar 26. Nefrologia (Engl Ed). 2021. PMID: 33775443 Free article. Review. English, Spanish.
Interleukin-17A: Potential mediator and therapeutic target in hypertension.
Rodrigues-Diez RR, Tejera-Muñoz A, Orejudo M, Marquez-Exposito L, Santos-Sanchez L, Rayego-Mateos S, Cantero-Navarro E, Tejedor-Santamaria L, Marchant V, Ortiz A, Egido J, Mezzano S, Selgas R, Navarro-González JF, Valdivielso JM, Lavoz C, Ruiz-Ortega M. Rodrigues-Diez RR, et al. Among authors: mezzano s. Nefrologia (Engl Ed). 2021 May-Jun;41(3):244-257. doi: 10.1016/j.nefroe.2021.06.003. Epub 2021 Jul 14. Nefrologia (Engl Ed). 2021. PMID: 36166242 Free article. Review.
162 results